
|Articles|November 1, 2019
- Pharmaceutical Executive-11-01-2019
- Volume 39
- Issue 11
Pharmaceutical Executive, November 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Pharm Exec’s 2020 Pipeline Reportalmost 7 years ago
R. Jude Samulski: Gene Therapy’s Guiding Forcealmost 7 years ago
The Pace of Massive Innovationalmost 7 years ago
The Quest to Measure Drug Effectivenessalmost 7 years ago
Biosensors in Pharma: A Dose of Optimismalmost 7 years ago
Closing the Science and Manufacturing Dividealmost 7 years ago
Country Report: SwedenAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Modern Policy Concerns Stemming from 340B
2
Funding Roundup: Silence Therapeutics, AbCellera Announce IPO Pricing, Beyang, Remepy Close Series A Financing
3
2026 Emerging Pharma Leaders
4
Preventing Cardiovascular Disease Through Mission-Driven Leadership
5



